Longevity PapersAbout
← All papers
RESEARCH PAPER / 2025-01-22

Hypoxia as a medicine.

Robert S Rogers, Vamsi K Mootha

Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA.Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA. · pubmed

Abstract

Oxygen is essential for human life, yet a growing body of preclinical research is demonstrating that chronic continuous hypoxia can be beneficial in models of mitochondrial disease, autoimmunity, ischemia, and aging. This research is revealing exciting new and unexpected facets of oxygen biology, but translating these findings to patients poses major challenges, because hypoxia can be dangerous. Overcoming these barriers will require integrating insights from basic science, high-altitude physiology, clinical medicine, and sports technology. Here, we explore the foundations of this nascent field and outline a path to determine how chronic continuous hypoxia can be safely, effectively, and practically delivered to patients.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

Chronic continuous hypoxia may have therapeutic benefits for aging and related conditions. The paper explores a novel approach to potentially address mechanisms of aging through hypoxia, which aligns with longevity research.

Author of this paper? Send a correction.